We are live on
!
Find out more
JA
JLB & Associates Portfolio holdings
AUM
$696M
1-Year Est. Return
17.86%
This Fund
S&P 500
This Quarter
Est. Return
+1.73%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
–
AUM
$219M
AUM Growth
–
Cap. Flow
+$221M
Cap. Flow
% of AUM
100.59%
Top 10 Holdings %
Top 10 Hldgs %
30.09%
Holding
73
New
73
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
McCormick & Company Non-Voting
MKC
|
+$7.94M |
| 2 |
Gilead Sciences
GILD
|
+$7.72M |
| 3 |
Oracle
ORCL
|
+$7.37M |
| 4 |
Accenture
ACN
|
+$6.95M |
| 5 |
Ametek
AME
|
+$6.69M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 18.21% |
| 2 | Healthcare | 17.02% |
| 3 | Consumer Discretionary | 16.96% |
| 4 | Industrials | 13.16% |
| 5 | Consumer Staples | 11.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Toro Company
TTC
$8.96B
| $3.97M | 1.81% |
+174,860
| New | +$4.03M |
|
|
ALTR
27
DELISTED
Altera Corp
ALTR
| $3.96M | 1.8% |
+119,975
| New | +$3.93M |
|
28
Apple
AAPL
$4.9T
| $3.93M | 1.79% |
+277,648
| New | +$4.27M |
|
29
Cracker Barrel
CBRL
$1.17B
| $3.69M | 1.69% |
+39,044
| New | +$3.4M |
|
30
Copart
CPRT
$25.7B
| $3.63M | 1.66% |
+943,296
| New | +$4.01M |
|
31
Tapestry
TPR
$28.9B
| $3.47M | 1.58% |
+60,740
| New | +$3.42M |
|
32
TJX Companies
TJX
$172B
| $3.37M | 1.54% |
+134,664
| New | +$3.32M |
|
|
COL
33
DELISTED
Rockwell Collins
COL
| $2.94M | 1.34% |
+46,289
| New | +$2.95M |
|
34
Dollar Tree
DLTR
$25B
| $2.9M | 1.32% |
+57,037
| New | +$2.78M |
|
35
AbbVie
ABBV
$457B
| $2.87M | 1.31% |
+69,328
| New | +$3.03M |
|
36
Amgen
AMGN
$200B
| $2.79M | 1.27% |
+28,279
| New | +$2.93M |
|
37
ExxonMobil
XOM
$613B
| $2.71M | 1.24% |
+29,978
| New | +$2.7M |
|
38
Expeditors International
EXPD
$23.7B
| $2.68M | 1.22% |
+70,379
| New | +$2.64M |
|
39
Abbott
ABT
$175B
| $2.65M | 1.21% |
+76,078
| New | +$2.79M |
|
|
PDCO
40
DELISTED
Patterson Companies, Inc.
PDCO
| $2.61M | 1.19% |
+69,354
| New | +$2.64M |
|
41
IBM
IBM
$198B
| $2.58M | 1.17% |
+14,100
| New | +$2.75M |
|
42
Cisco
CSCO
$440B
| $2.49M | 1.13% |
+102,254
| New | +$2.3M |
|
43
Danaher
DHR
$144B
| $2.4M | 1.09% |
+56,349
| New | +$2.33M |
|
|
NVO
44
Novo Nordisk
NVO
$223B
| $2.36M | 1.08% |
+152,420
| New | +$2.54M |
|
45
Kimberly-Clark
KMB
$36.3B
| $2.3M | 1.05% |
+24,667
| New | +$2.38M |
|
46
Labcorp
LH
$23.3B
| $2.08M | 0.95% |
+24,194
| New | +$2.01M |
|
47
Eli Lilly
LLY
$1.05T
| $1.62M | 0.74% |
+32,909
| New | +$1.79M |
|
48
Mettler-Toledo International
MTD
$26.4B
| $1.59M | 0.72% |
+7,890
| New | +$1.68M |
|
49
Bio-Techne
TECH
$11.2B
| $1.39M | 0.64% |
+80,720
| New | +$1.34M |
|
50
Canadian National Railway
CNI
$78.5B
| $1.3M | 0.59% |
+26,682
| New | +$1.32M |
|
Similar funds
AAM
CA
CA
FCM
GUB
AWC
BBPWM
SCM
JLB & Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for JLB & Associates, which disclosed 73 positions worth $219M. Its ten largest holdings account for 30% of the portfolio.
Its largest position is McCormick & Company Non-Voting: 220,524 shares worth $7.76M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, followed by Healthcare and Consumer Discretionary.
- JLB & Associates's largest Q2 2013 buy was McCormick & Company Non-Voting: 220,524 shares worth $7.76M.
- JLB & Associates's ten largest holdings make up 30% of its $219M portfolio in Q2 2013.
- JLB & Associates disclosed 73 positions in Q2 2013, its first 13F filing on record.
Based on JLB & Associates's 13F filing for Q2 2013, filed 12 Aug 2013.